IPSC Laboratory for CNS Disease Modeling
16 – 30 of 50
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Unique signatures of stress-induced senescent human astrocytes
(
- Contribution to journal › Article
- 2019
-
Mark
Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
(
- Contribution to journal › Article
-
Mark
Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
(
- Contribution to journal › Article
-
Mark
PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons
(
- Contribution to journal › Article
-
Mark
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
(
- Contribution to journal › Article
- 2018
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
Generation of an integration-free induced pluripotent stem cell line (CSC-43J) from a patient with sporadic Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation
(
- Contribution to journal › Article
-
Mark
Parkin absence accelerates microtubule aging in dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene
(
- Contribution to journal › Article
-
Mark
Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C > T and EX6 del) in the PARK2 gene
(
- Contribution to journal › Article
- 2017
-
Mark
Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes
(
- Contribution to journal › Article
-
Mark
Reporting on methods to generate and purify rodent and human oligodendrocytes from different sources
(
- Contribution to journal › Article
-
Mark
Differential alteration of hippocampal function and plasticity in females and males of the APPxPS1 mouse model of Alzheimer's disease
(
- Contribution to journal › Article